U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Links from BioSample

SRX10418051: GSM5202133: Patient-derived cell line -H2-; Homo sapiens; RNA-Seq
4 ILLUMINA (NextSeq 500) runs: 34M spots, 2.5G bases, 992.2Mb downloads

Submitted by: NCBI (GEO)
Study: Patient-derived glioblastoma stem cells transcriptome regulation by CD109
show Abstracthide Abstract
Glioma stem cells (GSCs) drive propagation and therapeutic resistance of glioblastomas, the most aggressive diffuse brain tumor. However, the molecular mechanisms that maintain the stemness and promote therapy resistance remain poorly understood. Here we study CD109 – STAT3 axis as crucial for the maintenance of stemness and tumorigenicity of GSCs and as a mediator of chemoresistance. Mechanistically, CD109 physically interacts with glycoprotein 130 (GP130) to promote activation of the IL-6/STAT3 pathway in GSCs. Genetic depletion of CD109 abolished the stemness and self-renewal of GSCs and impaired tumorigenicity. Loss of stemness was accompanied with a phenotypic shift of GSCs to more differentiated astrocytic-like cells. Importantly, genetic or pharmacologic targeting of CD109 – STAT3 axis sensitized the GSCs to chemotherapy suggesting that targeting CD109 – STAT3 axis has potential to overcome therapy resistance in glioblastoma. Overall design: Profiling of patient-derived glioblastoma stem cells according to the phenotypic subtypes identified by Neftel et al., 2019 (PMID 31327527) and investigation of the impact of CD109 silencing on the phenotypic states of Mesenchymal and Neuronal Precursor cells.
Sample: Patient-derived cell line -H2-
SAMN18437845 • SRS8538985 • All experiments • All runs
Organism: Homo sapiens
Library:
Instrument: NextSeq 500
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: SINGLE
Construction protocol: Total RNA was extracted from lysed cells or gliospheres using the RNeasy Mini kit (#74104) (Qiagen) according to the manufacturer's instructions. After DNase treatment, the quality of the RNA preparations (1 µg) was controlled using a Tapestation (Agilent). Total RNA 1 ug is treated with Illumina's Ribo-Zero Complete Gold Kit to remove the ribosomal RNA. First the samples are treated with rRNA removal solution after which the rRNA is removed combining probe-hybridized samples and magnetic beads. The Ribo-Zero treated RNA is purified with Qiagen RNeasy MinElute Cleanup Kit. The absence of rRNA is assessed by Bioanalyzer and the quantity of RNA by Bioanalyzer. NEBNext Ultra Directional RNA Library Prep Kit for Illumina (NEB #E7420S/L Version 8.0 3/16) is used to generate cDNA libraries for next generation sequencing. First, the ribosomal RNA depleted sample (10 ng) is fragmented to generate inserts around 200 bp, and then primed with random primers. The first strand cDNA synthesis utilizes Actinomycin D, which inhibits the DNA polymerase activity of the reverse transcriptase increasing strand specificity. In the second strand cDNA synthesis dUTP labelled oligo nucleotides are incorporated to mark the second strand with uracils (U). The cDNA synthesis product is purified with Agencourt AMPure XP beads. Next, the cDNA is end-repaired, and adapter ligated utilizing dA-tailing. The adaptor ligated DNA goes through a bead-based size selection after which the final PCR enrichment takes place. At this point, each sample is given a unique index to enable pooling of multiple samples (multiplexing) for sequencing. During the high-fidelity PCR, USER (Uracil-specific Excision Reagent) enzyme cuts away the uracil strand preserving only the first strand. In addition, the loop adaptor is cut open to enable the PCR. The amplified library is then purified using AMPure XP Beads. Library quality is assessed by Bioanalyzer (Agilent DNA High Sensitivity chip) and library quantity by Qubit (Invitrogen). Illumina NextSeq 500 High Output 75 cycle kit for single-end 1x75bp reads (2 flow cells). Loading concentration 1,5 pM + 1% PhiX control. Starting amount of Total RNA: 1000 ng, PCR cycles used in method: 15.
Experiment attributes:
GEO Accession: GSM5202133
Links:
Runs: 4 runs, 34M spots, 2.5G bases, 992.2Mb
Run# of Spots# of BasesSizePublished
SRR140418548,579,355638M250.6Mb2021-03-24
SRR140418557,946,826590.6M239.5Mb2021-03-24
SRR140418568,762,892651.7M252.5Mb2021-03-24
SRR140418578,712,057648M249.6Mb2021-03-24

ID:
13736202

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...